Author

V. Chenouard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:rat· 3 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

I. Anegon· 3 shared L. Tesson· 3 shared S. REMY· 3 shared C. Guillonneau· 2 shared L.-H. Ouisse· 2 shared A. Chenouard· 1 shared A. Fortun· 1 shared A. Guiffes· 1 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

I. Anegon

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CD4+ and CD8+ regulatory T cells characterization in the rat using a unique transgenic Foxp3-EGFP model.

S. MENORET, L. Tesson, S. REMY, V. Gourain, C. Serazin, C. Usal, A. Guiffes, V. Chenouard, L.-H. Ouisse, M. Gantier, J.-M. Heslan, C. Fourgeux, J. Poschmann, C. Guillonneau, I. Anegon

The paper develops a rat transgenic model with Foxp3-EGFP to study CD4+ and CD8+ regulatory T cells, revealing their frequencies, markers, suppressive activity, and transcriptome.

bioRxiv · Dec 9, 2021 · PreprintImmunology

Highly Efficient Knockin in Human iPS Cells and Rat Embryos by CRISPR/Cas9 Molecular Optimization

V. Chenouard, I. Leray, L. Tesson, S. Remy, A. Fortun, K. Bernardeau, Y. Cherifi, L. David, I. Anegon

This study optimizes CRISPR/Cas9 reagent concentrations for efficient knockin in human iPS cells and rat embryos, achieving 50% knockin efficiency with reduced costs and toxicity.

bioRxiv · Sep 3, 2021 · PreprintBioengineering

Immunological characterization of a rat model of Duchenne’s disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment

L.-H. Ouisse, S. Remy, A. Lafoux, T. Larcher, L. Tesson, V. Chenouard, C. Guillonneau, L. Brusselle, N. Vimond, K. Rouger, Y. Pereon, A. Chenouard, C. Gras-Le Guen, C. Braudeau, R. Josien, , I. Anegon

This study characterizes immune responses in a rat model of Duchenne’s disease and shows that anti-CD45RC antibody treatment improves muscle strength without side effects.

bioRxiv · Sep 3, 2018Immunology